# Sanofi: Observational study completed, 4878935 enrolled (Chlamydial Infections)

**Score:** 60/100

| Field | Value |
|---|---|
| Sponsor | Sanofi |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data |
| NCT ID | NCT07094373 |
| Phase | Observational |
| Status | completed |
| Conditions | Chlamydial Infections |
| Target enrollment | 4878935 |
| Site countries | United States |
| Posted | 2025-07-30 |
| Planned start | 2025-01-01 |
| Event | Completed |
| Event date | 2026-09-30 |
| Last update posted | 2026-10-13 |

## Why this score
- Industry sponsor (buys outsourced services).
- Completed: closeout, analysis and the next study ahead.
- 4878935 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07094373). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.